Gilead Sciences (GILD) Market Cap 1992–2026

As of November 13, 2026, Gilead Sciences had a market cap of $208.59 billion, which increased by 0.08% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.

Data updated: Nov 13, 2026, 4:00 PM ET
Gilead Sciences logo

Gilead Sciences Inc. (GILD)

🌍 United States 📈 NASDAQ 🏭 Health Care 🏢 Biotechnology
Latest Market Cap
$208.59B ▲ 0.08%
Start of 2026
$152.28B ▲ 36.98%
1 Year Ago
$155.33B ▲ 34.29%
All-Time High
$216.53B ▼ 3.67%


Loading data...


Note: Each point on the chart represents the market capitalization at the end of the trading day.
Source: Data compiled from EDGAR filings, Bloomberg and Yahoo Finance.

📈 Gilead Sciences Market Cap History by Year and Month

Gilead Sciences Market Cap History by Year and Month
Year / MonthMarket Cap% Change
2026$208.59B▲ 36.98%
$208.59B▼ 1.52%
$211.81B▲ 14.51%
$184.97B▲ 1.85%
$181.61B▲ 12.30%
$161.72B▲ 3.07%
$156.91B▼ 5.99%
$166.9B▲ 2.75%
$162.43B▼ 6.12%
$173.02B▼ 6.43%
$184.91B▲ 5.00%
$176.11B▲ 15.65%
2025$152.28B▲ 32.31%
2024$115.093B▲ 14.02%
2023$100.938B▼ 6.24%
2022$107.656B▲ 18.23%
All market cap values reflect closing prices for the period shown.

📊 Gilead Sciences Market Cap and Other Industry Peers

Below are selected companies for comparison based on industry, sub-industry, and sector:

  1. $251.88B
  2. $208.59B
  3. $136.55B
  4. $98.8B
  5. $90.24B
  6. $46.06B
  7. $37.45B
  8. $37.26B
  9. $28.61B
  10. $26.57B
  11. $25.06B
  12. $24.68B
  13. $22.09B
  14. $16.96B
  15. $16.88B
  16. $15.35B
  17. $11.42B
  18. $11.32B
  19. $11.08B
  20. $10.88B


Data reflect the most recent market capitalization values available.

Note: Market capitalization figures are based on available sources and may differ slightly from actual values, particularly for historical data.